DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20160674

Endometrial carcinoma in young women: management options and its review

Anshika Lekhi, Rahul Manchanda, Nidhi Jain, Sravani Chithra, Hena Kausar

Abstract


Endometrial carcinoma is a disease of older postmenopausal women, and is relatively uncommon in patients younger than 40 years. The incidence in young women is 2%-14%. Endometrial carcinomas in this age group may be familial, associated with Lynch syndrome, or sporadic. Patients usually have increased exposure to estrogen. Its treatment includes hysterectomy, bilateral salpingoophorectomy and pelvic lymphadenectomy and in some cases, radiation therapy. Preservation of fertility is a major challenge encountered in such cases. Before deciding on the management of any patient with abnormal bleeding a hysteroscopic examination with biopsy should be performed for all the patients, as hysteroscopy make it easy to visualize the cavity and to obtain the biopsy from the specific site. We have reviewed the literature of endometrial cancer management in young women through a case in a 35-year-old woman with previous 3 cesarean treated for abnormal uterine bleeding. We performed Hysteroscopy which showed adenocarcinoma endometrium on histopathology. Most endometrial carcinomas presenting in this young age are associated with estrogen excess. Pathologically they are usually low-grade endometrioid carcinomas with lower stage and are associated with favourable clinical outcomes. With this review the authors emphasize the need of hysteroscopic endometrial reckoning in young females with abnormal bleeding before starting any medical treatment. Also highlighting the management options in such cases where fertility preservation holds a significant challenge.

Keywords


Adenocarcinoma, Endometrial carcinoma, Management, Risk factor, Young patient

Full Text:

PDF

References


Colafranceschi M, Taddei GL, Scarselli G, Branconi F, Tinacci G, Savino L. Clinico-pathological profile of endometrial carcinoma in young women (under 40 years of age). Eur J Gynaecol Oncol. 1989;10(5):353-6.

Crissman JD, Azoury RS, Barnes AE, Schellhas HF. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol. 1981;57(6):699-704.

Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF. Endometrial cancer in women 40 years old or younger. Gynecol Oncol. 2001;83(2):388-93.

Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol. 1984;64(3):417-20.

Ota T, Yoshida M, Kimura M, Kinoshita K. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer. 2005;15(4):657-62.

Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10-7.

Smith M, McCartney AJ. Occult, high-risk endometrial cancer. Gynecol Oncol. 1985;22(2):154-61.

Potischman N, Hoover RN, Brinton LA. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88:1127-35.

Girardi J, Goodheart MJ. Diagnosis of endometrial cancer complicated by morbid obesity: a case report. Proc Obstet Gynecol. 2011;2(1):5.

Shibahara H, Shigeta M, Toji H. Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection. Hum Reprod. 1999;14:1908-11.

Shammel DP, Mittel KR, Kaplan K, Delgodisch L. Endometrial adenocarcinoma associated with intrauterine pregnancy: a report of 5 cases and review of the literature. Int J Gynecol Pathol. 1998;17:327-35.

Park RC. Uterine cancer. In: Hoskins WJ, editor. Principles and Practice of Gynecologic Oncology. Philadelphia: Lippincott Williams and Wilkins. 2006:663-93.

Yamazawa K, Hirai M, Fujito A. Fertility preserving treatment with progestin and pathological criteria to predict responses in young women with endometrial cancer. Hum Reprod. 2007;22:1953-8.

Emons G, Shroder B, Ortmann O, Westphalen S. High affinity binding and direct antiproliferative effects of luteinizing hormone- releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab. 1993;77:1458-64.

Yasuda M, Terai Y, Sekijima T, Sasaki H. Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman. Fertil Steril. 2009;91:936,e13-5.

Sodano M, Bogliatto F, Morero S, Mosso L, Torchio B, Leidi L. Case report: Successful IVF programme after conservatively treated endometrial cancer.Reprod Biomed Online. 2009;18(4):578-81.

Chiva L, Lapuente F, Gonzalez-Cortijo L. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol. 2008;111:101-4.